Certara, a Princeton-based biosimulation company, has filed for an initial public offering that at least one report estimates could be worth up to $500 million.
Certara’s filing with the Securities and Exchange Commission lists the potential value of the IPO at $100 million. However, research and investment management site Renaissance Capital said in a report that the filing figure appears to be a placeholder, and the firm suggested the offering could raise up to half a billion dollars.
The company’s common stock would trade on the Nasdaq Global Select Market under the symbol “CERT.”
